a drug that is used to treat tuberculosis (TB) and to prevent it in people who have had contact with tuberculosis bacteria
an antibacterial drug used to treat tuberculosis.
the drug that is most often used for preventive therapy and also used to treat TB disease; although relatively safe, it may cause hepatitis and other adverse reactions in some patients
an antibiotic used in combination regimens to treat tuberculosis. Side effects include liver toxicity and peripheral neuropathy.
Indications: Treatment of TB in combination with other agents; prophylaxis of TB in context of positive PPD. Contraindications: Known hypersensitivity, significant hepatic disease. Dosage: Treatment: 300 mg po qd (or 900 mg twice a week [DOT]); prophylaxis: 300 mg po qd for nine months. Pyridoxine should be given concurrently for prevention of peripheral neuropathy. Toxicity: Hepatotoxicity, especially in alcoholics and persons older than 50; peripheral neuropathy; fever; rash. Pregnancy category C.
a drug used to prevent TB disease in people who have TB infection. Isoniazid is also one of the five drugs used to treat TB disease.
An orally administered drug used to eliminate tuberculosis infection in people without active disease. INH is also administered in combination with other drugs to treat active tuberculosis
the drug most often used for preventive therapy and also used to treat TB disease. Sometimes referred to as INH.
Isoniazid (also called isonicotinyl hydrazine or isonicotinic acid hydrazide) is often abbreviated INH. Isoniazid is a first-line antituberculous medication used in the prevention and treatment of tuberculosis. However, monotherapy with Isoniazid is not recommended due to high rates of resitance.